Inovio Pharmaceuticals (INO) Squeeze Risk
As of the most recent market data, Inovio Pharmaceuticals (INO) has emerged as a primary target for short squeeze activity. According to data from Tapeboard, INO currently holds a Short Squeeze Score of 99.4/100. This elevated score is underpinned by a substantial short interest position representing 22.2% of the company's float.
Market Dynamics
The high short interest percentage indicates that a significant portion of the market is betting against the stock's performance. When a stock with such high short interest experiences a positive price catalyst, the resulting 'short squeeze' can force those holding short positions to buy back shares to cover their losses, further driving up the price. Investors should monitor the stock for increased volatility and potential rapid price movements as the high short interest creates a precarious environment for those currently short the stock.
Key Takeaways
- INO leads the current short squeeze leaderboard with a 99.4/100 score.
- Short interest stands at 22.2% of the float.
- High short interest levels increase the probability of a short squeeze if positive momentum occurs.
The Bottom Line
INO represents a high-risk, high-reward scenario where the current short interest levels suggest significant potential for a squeeze if market conditions shift in favor of the bulls.
Signal data sourced from Tapeboard. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.